![]() A comprehensive approach to assessing COVID-19 community levels can inform decisions about layered COVID-19 prevention strategies (Figure 1), including vaccination and masking, with explicit goals of reducing medically significant disease and limiting strain on the healthcare system. ![]() 10-11 Accordingly, at this stage of the pandemic, data on disease severity and healthcare system strain to complement case rates are more informative for public health recommendations for individual, organizational, and jurisdictional decisions than data on community transmission rates alone. A burdened healthcare system is associated with increased mortality associated with COVID-19 9-10 and limits capacity and resources for medical care for non-COVID-19 conditions. 29 These changes make it more feasible to minimize medically significant disease and prevent excessive strain on the healthcare sector, even in the occurrence of SARS-CoV-2 transmission. Despite high volume of hospitalizations due to high caseloads, the emergence of Omicron as the dominant variant reflected lower virulence and disease severity. However, note that these prices are only indicative of how much govts and hospitals will pay to procure doses from the manufacturers, people getting vaccinated will end up paying more to cover any charges the hospital or the govt might choose to levy.Widespread uptake of COVID-19 vaccines that are highly effective against severe illness and death, 1-4 the accrual of high rates of vaccine- and infection-induced immunity at the population level, 5-7 and the availability of effective therapeutics 8 have moved the pandemic to a different phase. Covaxin by Bharat Bio will cost Rs 600 for govt hospitals and Rs 1,200 for private hospitals. Covishield by Serum Institute will cost Rs 400 for govt hospitals and Rs 600 for private hospitals. Many state govts have annouced free vaccination for everyone above 18 years of age. In the phase 3 of Covid-19 vaccination in India, everyone above the age of 18 to be eligible to get Covid-19 vaccine from May 01, 2021.Covishield, Covaxin and Sputnik V are the three Covid-19 vaccines that have been approved by the central govt of India. The phase 2 vaccinations started on March 1, 2021, where all Indians above the age of 60 and Indians between the age of 45 and 59 with comorbidities were vaccinationated. In the phase 1 of the Covid-19 immunisation programme, all health and frontline workers were eligible to take the shot. As of April 2021, India has the second-highest number of confirmed Covid-19 positive cases in the world (after the United States) with more than 17 million reported cases of COVID-19 infection and 192,311 deaths as of April 25, 2021.India began its Covid-19 vaccination programme on 16 January 2021 with over 160,000 doses administered on the first day. The biggest worry is that 80-85% of the population in India are asymptomatic and continue to be the largest carrier of the coronavirus. The Covid-19 positive cases in India had started to drop significantly from September 2020, however, it started rising again under a second wave from March 2021.The second wave of Covid-19 pandemic in India is proving to be more devastating than the first. Countries around the world have taken strict decisions to close the entry of foreigners, schools, colleges, gyms, clubs, cinema halls, malls and other public places to stop the spread of Covid-19. Within weeks, the coronavirus spread outside of the country to other nations like South Korea, Iran, Italy, United States, India, Pakistan among others. The outbreak of coronavirus infection soon spread to other provinces of the country, forcing the govt to lockdown dozen of cities with millions of people. Later, its root was traced to a novel strain of coronavirus. The first case of coronavirus was reported in December 2019 in the Wuhan city of China as a pneumonia outbreak.
0 Comments
Leave a Reply. |